Salina ‘Battle of the Badges’ Blood Drive underway

by: Wil Day Posted: Aug 28, 2023 / 02:39 PM CDT Updated: Aug 28, 2023 / 02:39 PM CDT SALINA, Kan. (KSNW) — The annual “Battle of the Badges” is underway in Salina. Each year the Salina Police Department and Salina Fire and EMS compete to see who can get the most people to donate blood and vote for them in the event sponsored by the American Red Cross. Barton County sheriff: Man lying on road is hit by car The drive began Monday morning and runs through Wednesday. Those who participate with a blood donation and vote either for police or fire and EMS can receive a free t-shirt while supplies last. For more information, including times, location, and scheduling an appointment, click here.

GOP Presidential Candidate Ron DeSantis Has The Blood of Jacksonville’s Black Community On His Hands

At a vigil Sunday for the people killed by a mass shooter in Jacksonville, Fla., Gov. Ron DeSantis was loudly booed and heckled by attendees. A day prior, a white gunman targeted and shot three Black people to death at a Dollar General store before fatally turning the gun—an AR-15 he adorned with swastikas—on himself. Black Hack: Clean the Tub And Save Your Back! Off English “What he did is totally unacceptable in the state of Florida,” DeSantis said. “We are not going to let people be targeted based on their race.” Advertisement The governor—who we often find much to disagree with—wasn’t wrong there. Racially-motivated mass killings should be unacceptable in Florida or anywhere else. And as the state’s top elected official, the buck absolutely stops with him. But DeSantis left out one critical detail as he did his civic duty to condemn the violence: the fact that he has to own some responsibility for creating the climate in which it happened. No, he didn’t put the gun in the murderer’s hands, etch the swastikas or pull the trigger. He didn’t write the manifesto. But DeSantis, who is currently seeking the GOP nomination for president, has used his power to bolster racial division through policies that demean and diminish Black people, Hispanic immigrants and member of the LGBTQIA community. Advertisement Advertisement Whether it was the Stop WOKE Act” which severely limits how companies and school can discuss race, to gutting diversity programs at colleges, DeSantis has used the levers of power to specifically demonize Black people—and our history—in attempt to appease a bigoted political party and make white people feel better. In a move earlier this year that even shocked Republicans, the Florida Board of Education approved a new set of African-American Studies teaching standards that claimed Black people personally benefited from slavery. DeSantis’ Republican Party has for decades purported to care about law and order, but the Florida gov saw fit to suspend two elected prosecutors—including the only Black woman in that role in the state—when how they did their job wasn’t politically convenient for him. In addition to his crusade against critical race theory, DeSantis also made it easier for the Jacksonville shooter to purchase his weapon by loosening gun laws in Florida during his tenure. For the governor to feign empathy and call the perpetrator a “major league scumbag” Sunday night is a joke; DeSantis intentionally cultivated the grounds for this atrocious act of violence to occur. In May, the NAACP issued a formal travel advisory for the state of Florida explaining it wasn’t safe for Black people. Advertisement “Florida is openly hostile toward African Americans, people of color and LGBTQ+ individuals,” the travel notice stated. “Before traveling to Florida, please understand that the state of Florida devalues and marginalizes the contributions of, and the challenges faced by African Americans and other communities of color.” Shortly after the advisory was released, a spokesperson for DeSantis wrote it off as “nothing more than a stunt.” Now we know who was right. However, what happened on Saturday proved that politicians who normalize white supremacist rhetoric used by domestic terrorists play a crucial role in the rise of hate crimes. DeSantis and others like him who prop up white nationalism have blood on their hands—and Black folks won’t ever forget it.

COVID-19: New Variant With 30 Mutations May Cause Breakthrough Infections, CDC Warns

The BA.2.86 strain, now known as Pirola, has been identified in three states: Michigan, Virginia, and Ohio. The Michigan case, the first in the US, was an older woman who had recently returned from Japan. “BA.2.86 may be more capable of causing infection in people who have previously had COVID-19 or who have received COVID-19 vaccines,” the CDC said in a Risk Assessment Summary. “Scientists are evaluating the effectiveness of the forthcoming, updated COVID-19 vaccine. “CDC’s current assessment is that this updated vaccine will be effective at reducing severe disease and hospitalization. “At this point, there is no evidence that this variant is causing more severe illness. That assessment may change as additional scientific data are developed. CDC will share more as we know more.” At a World Health Organization (WHO) news briefing on Friday, Aug. 25, authorities said they consider BA.2.86 to be part of the Omicron variant family, but that could change if the strain spreads more widely even though Pirola’s 30 mutations are from the BA.2 lineage, which was the dominant Omicron strain in 2022. More data on the strain is expected later this week. The Pirola strain was first detected in Israel, and cases have also been identified in several other countries, including the US, United Kingdom, South Africa, and Denmark. Currently, a new Omicron subvariant known as Eris, whose official name is EG.5, is accounting for most COVID cases nationwide, just ahead of the XBB.1.16 strain, according to estimates by the CDC. Arcturus is also an offshoot of the highly-contagious Omicron strain. Check back to Daily Voice for updates. Click here to follow Daily Voice Nassau and receive free news updates.

Carter BloodCare to host blood drives in southern Denton County – Cross Timbers Gazette | Southern Denton County | Flower Mound

Carter BloodCare recently announced that it will host several blood drives in different parts of southern Denton County in September as part of Sickle Cell Awareness Month. “Sickle cell disease restricts the ability of hemoglobin in red blood cells to carry oxygen throughout the body,” the organization said in a news release. “This can lead to fatigue, strokes, intense pain, shortness of breath, headaches, dizziness and organ failure. Texas-based nonprofit Carter BloodCare notes blood transfusions are key treatments to relieve sickle cell symptoms.” Sickle cell disease is an inherited blood disorder that affects about 100,000 Americans. “Eligible donors can easily support neighbors in need and others requiring transfusions,” Carter BloodCare said in a statement. “Give blood at this month’s Carter BloodCare blood drive.” The Carter BloodCare Bus will conduct a blood drive on Sept. 7, from 8:30 a.m. to 1 p.m., at Texas Health Presbyterian Hospital, 4400 Long Prairie Road in Flower Mound. Click here to sign up. Then on Sept. 17, the Carter BloodCare Bus will be at St. Mark’s Catholic Church, 6500 Crawford Road in Argyle, from 7:45 a.m. to 1:30 p.m. Click here to sign up. And on Sept. 23, the Carter BloodCare Bus will conduct another blood drive at Double Oak Veterinary Medical Center, 8351 Justin Road, from 10:30 a.m. to 2:30 p.m. Click here to sign up.

Unmet Needs in Oligometastatic Prostate Cancer

Chad Tang, MD, The University of Texas MD Anderson Cancer Center, discusses the unmet needs for patients with oligometastatic prostate cancer. There have been randomized trials for oligometastatic prostate cancer, including STOMP (NCT01558427) and ORIOLE (NCT02680587), which randomized patients to receive radiation in metastatic patients vs observation. These trials showed that radiation delayed the PSA progression that occurs among this patient population, and radiation by itself, delays the progression. According to Tang, other trials have also shown that radiation therapy can combine synergistically with hormone therapy. In earlier trials, upfront hormonal therapy for metastatic disease has also resulted in benefits in overall survival when compared with delaying hormone therapy. Advertisement Then, the EXTEND trial (NCT03599765) recently evaluated patients with oligometastatic prostate cancer and showed there to be improvements in progression-free survival (PFS) and eugonadal PFS when given the combination of metastasis-directed therapy with intermittent hormone therapy. However, Tang notes that questions still remain regarding how experts think about oligometastatic prostate cancer, the way it is defined, and how it is treated. Transcription: 0:10 | I think the biggest unmet need is how we think about oligometastatic prostate cancer. In my opinion, there are 2 ways that you can change therapy with high level evidence. One is to do a randomized control compared with standard of care and number 2 is staging changes. With PSMA PETS and with improved imaging overall, maybe we need to better define, biologically, what oligometastatic prostate cancer is. If that’s true, then maybe we should treat them like metastatic prostate cancers to understand these processes a little bit better and find the optimum treatment recommendations for these patients. REFERENCE: Tang C, Sherry AD, Haymaker C, et al. Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): A multicenter, randomized phase II trial. J Radiat Oncol. 2022;114(5):P1059-1060. doi:10.1016/j.ijrobp.2022.09.006

Fungal Lung Disease Makes World’s Deadliest Bacteria Even Worse

In Tanzania, researchers are unlocking the mysteries of a mold (fungus) that infects patients who have already contracted the bacterial disease tuberculosis. According to World Health Organization statistics, tuberculosis is the leading cause of death globally from infectious disease, with over a quarter of TB deaths occurring in Africa. Fungal lung disease, particularly chronic pulmonary aspergillosis is significantly under-diagnosed, under-treated and a common cause of death in Africa: a 2022 study found the Aspergillosis mold develops in the lesions caused by TB, worsening them and resulting in a deteriorating clinical situation. Dr Martha F. Mushi, a lecturer consultant medical mycologist, at the Catholic University of Health and Allied Sciences (CUHAS) and Bugando Medical Centre in Mwanza, Tanzania, explaines that her research explores the prevalence, risk factors, and clinical outcomes of CPA among patients with smear-negative (lower bacterial load) TB, contributing to improved patient care in vulnerable populations. “The fact that approximately 45% of clinically diagnosed pulmonary TB cases have negative-smear or PCR test results highlighted the need of this project,” she says, adding that while CPA is documented as the major cause of smear negative TB, the mortality rate of untreated CPA is estimated at 75% to 80% over five years. “Africa’s capacity to diagnose lung fungal infection is still very low,” she says, “This calls for the global attention in increasing awareness of fungal infection among clinicians and training of technical staff (radiology and clinical laboratory) on the WHO essential diagnostic tests, to attain the sustainable development goals.” Mushi explained that the project is a result of collaboration with Prof David Denning, the founder and retired executive director of Global Action Fund for Fungal Infections (GAFFI), which partially funds and supports the project. Dr Martha Mushi reading gram stain results all in in microbiology laboratory of CUHAS with taken on … [+] 30th June 2023 Martha Mushi Importance of Mycology Mushi grew up in in Kilimanjaro region Northeastern part of Tanzania. “As a university student I was very much inspired by my microbiology professor, who interested me in this field that explores the intricate world of microorganisms,” she says, adding that the neglect of mycology as a whole result in limited research funding, making it challenging to generate evidence-based data for teaching and to foster interest among junior researchers. “Despite these obstacles, mycology plays a crucial role in understanding and addressing fungal infections, which have significant impacts on public health,” she says. According to Mushi, addressing public health issues requires more than just medical interventions. “Scientists from the Global South understand the local healthcare systems, traditional healing practices, community dynamics, and social determinants of health,” she says, “This understanding enables them to design interventions that are sensitive to cultural beliefs and practices, promote community engagement, and enhance the likelihood of successful implementation. Mushi explains that scientists from the Global South can shed light on ethical dilemmas specific to their contexts and ensure that research is conducted in a way that respects the dignity, autonomy, and rights of individuals and communities. “This not only enhances the relevance and applicability of the solutions but also promotes a sense of ownership and empowerment among the communities affected by the global challenges,” she says. Mwanza, Tanzania. getty Phage Approach Another researcher from the region interested in tuberculosis is 20-year old Rutendo Kahari. Kahari, from Zimbabwe, is already on a path to use viruses that infect bacteria to fight some of sub-Saharan Africa’s deadliest infectious diseases. The budding biomedical researcher interested in bacteriophages (viruses that whose hosts are bacteria) and genetic engineering as potential tools for fighting TB and other infectious diseases. Recent studies have focused on phage-based treatments as a solution to treating multidrug-resistant tuberculosis. After hearing a podcast on bacteriophages, Kahari delved into how phages could potentially combat the spread of antibiotic-resistant bacteria. “I was intrigued by the idea of using viruses to control populations of pathogenic bacteria,” she says.

Intravascular imaging-guided PCI improves patient outcomes, new meta-analysis confirms

The final analysis included data from the ILUMIEN IV trial, OCTOBER trial and several previously completed studies comparing intravascular imaging-guided PCI and angiography-guided PCI. Adding up all of the included trials, researchers were left to compare 7,038 patients treated with intravascular imaging-guided PCI, including 3,120 who underwent IVUS-guided PCI, 2,826 who underwent OCT-guided PCI and another 1,029 who were randomized to undergo IVUS- or OCT-guided PCI. These patients were compared with 5,390 treated with angiography-guided PCI, and each participant was followed for a period of 6 months to five years. The primary endpoint of the meta-analysis was target lesion failure, which the authors defined as a composite of cardiac death, target vessel myocardial infarction (MI) or target lesion revascularization. Overall, intravascular imaging-guided PCI helped reduce that composite endpoint by 31%. It also was linked to significant reductions in cardiac death, target vessel MI, target lesion revascularization and stent thrombosis. “The results of this network meta-analysis emphasize the importance of physicians using intravascular imaging with either OCT or IVUS to optimize stent outcomes and improve the long-term prognosis of their patients,” Gregg Stone, MD, a cardiologist and professor of cardiology with Icahn School of Medicine at Mount Sinai in New York, said in a statement. Additional ESC Congress 2023 coverage is available here, here and here.